SPHK2 and leukemia: Liu’s group29 found that K145 can act as a dual pathway inhibitor and inhibit both ART and AKT signaling pathway phosphorylation while inhibiting SPHK2, thereby achieving antiproliferative and apoptotic effects in U937 leukemia cells.